High free thyroxine levels are associated with QTc prolongation in males

Journal of Endocrinology

Volumn 198, Issue 1, 2008, Pages 253-260

  van Noord, Charlotte ^a,c   van der Deure, Wendy M ^a   Sturkenboom, Miriam C J M ^a   Straus, Sabine M J M ^a,c   Hofman, Albert ^a   Visser, Theo J ^a   Kors, Jan A ^a   Witteman, Jacqueline C M ^a   Stricker, Bruno H Ch ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Inspectorate for Health Care   (Netherlands)

^c MEDICINES EVALUATION BOARD   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; THYROID HORMONE DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; GENDER; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT BUNDLE BRANCH BLOCK; HIGH RISK POPULATION; HORMONE DETERMINATION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; THYROXINE BLOOD LEVEL;

AGED; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS; THYROTROPIN; THYROXINE;

EID: 47849083608     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0140     Document Type: Article

References (48)

1. Abalovich M, Levalle O, Hermes R, Scaglia H, Aranda C, Zylbersztein C, Oneto A, Aquilano D & Gutierrez S 1999 Hypothalamic-pituitary-testicular axis and seminal parameters in hyperthyroid males. Thyroid 9 857-863.
2. Al-Khatib SM, LaPointe NM, Kramer JM & Califf RM 2003 What clinicians should know about the QT interval. Journal of the American Medical Association 289 2120-2127.
3. Bai CX, Kurokawa J, Tamagawa M, Nakaya H & Furukawa T 2005 Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 112 1701-1710.
4. Bazett HC 1920 The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. Journal of Physiology 53 320-339.
5. van Bemmel JH, Kors JA & van Herpen G 1990 Methodology of the modular ECG analysis system MEANS. Methods of Information in Medicine 29 346-353.
6. Binah O, Arieli R, Beck R, Rosen MR & Palti Y 1987 Ventricular electrophysiological properties: is interspecies variability related to thyroid state? American Journal of Physiology 252 H1265-H1274.
7. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC & Stricker BH 2004 Quantifying the heart failure epidemic: prevalence, incidence race, lifetime risk and prognosis of heart failure The Rotterdam Study. European Heart Journal 25 1614-1619.
8. Bots ML, Hoes AW, Koudstaal PJ, Hofman A & Grobbee DE 1997 Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction: The Rotterdam Study. Circulation 96 1432-1437.
9. Brown DW, Giles WH, Greenlund KJ, Valdez R & Croft JB 2001 Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. Journal of Cardiovascular Risk 8 227-233.
10. de Bruyne MC, Kors JA, Hoes AW, Kruijssen DA, Deckers JW, Grosfeld M, van Herpen G, Grobbee DE & van Bemmel JH 1997 Diagnostic interpretation of electrocardiograms in population-based research: computer program research physicians, or cardiologists? Journal of Clinical Epidemiology 50 947-952.
11. Colzani RM, Emdin M, Conforti F, Passino C, Scarlattini M & Iervasi G 2001 Hyperthyroidism is associated with lengthening of ventricular repolarization. Clinical Endocrinology 55 27-32.
12. CPMP/986/96 1997 The assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products. London: Committee for proprietary medicinal products.
13. Darpo B, Agin M, Kazierad DJ, Layton G, Muirhead G, Gray P & Jorkasky DK 2006 Man versus machine: is there an optimal method for QT measurements in thorough QT studies? Journal of Clinical Pharmacology 46 598-612.
14. Davey PP, Barlow C & Hart G 2000 Prolongation of the QT interval in heart failure occurs at low but not at high heart rates. Clinical Science 98 603-610.
15. Dorr M, Ruppert J, Robinson DM, Kors JA, Felix SB & Volzke H 2006 The relation of thyroid function and ventricular repolarization: decreased serum thyrotropin levels are associated with short rate-adjusted QT intervals. Journal of Clinical Endocrinology and Metabolism 91 4938-4942.
16. Fazio S, Biondi B, Lupoli G, Cittadini A, Santomauro M, Tommaselli AP, Lombardi G & Sacca L 1992 Evaluation, by noninvasive methods, of the effects of acute loss of thyroid hormones on the heart. Angiology 43 287-293.
17. Ferrini RL & Barrett-Connor E 1998 Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. American Journal of Epidemiology 147 750-754.
18. Fisher J 1982 Thyrotoxic periodic paralysis with ventricular fibrillation. Archives of Internal Medicine 142 1362-1364.
19. Gaudron P, Kugler I, Hu K, Bauer W, Eilles C & Ertl G 2001 Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. Journal of the American College of Cardiology 38 33-40.
20. Gomberg-Maitland M & Frishman WH 1998 Thyroid hormone and cardiovascular disease. American Heart Journal 135 187-196.
21. Gray A, Berlin JA, McKinlay JB & Longcope C 1991 An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. Journal of Clinical Epidemiology 44 671-684.
22. Harjai KJ & Licata AA 1997 Effects of amiodarone on thyroid function. Annals of Internal Medicine 126 63-73.
23. Hofman A, Grobbee DE, de Jong PT & van den Ouweland FA 1991 Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. European Journal of Epidemiology 7 403-422.
24. Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, Tiemeier H, Uitterlinden AG, Vingerling JR & Witteman JC 2007 The Rotterdam Study: objectives and design update. European Journal of Epidemiology 22 819-829.
25. + outward current in cardiomyocytes from thyroid hormone receptor alpha1-deficient mice. Journal of Cardiovascular Electrophysiology 13 44-50.
26. Johnson PN, Freedberg AS & Marshall JM 1973 Action of thyroid hormone on the transmembrame potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology 58 273-289.
27. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA & Breteler MM 2000 Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clinical Endocrinology 53 733-737.
28. Kulan K, Ural D, Komsuoglu B, Agacdiken A, Goldeli O & Komsuoglu SS 1998 Significance of QTc prolongation on ventricular arrhythmias in patients with left ventricular hypertrophy secondary to essential hypertension. Internal Journal of Cardiology 64 179-184.
29. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM & Bor DH 2002 Timing of new black box warnings and withdrawals for prescription medications. Journal of the American Medical Association 287 2215-2220.
30. Linder MA 1955 Periodic paralysis associated with hyperthyroidism: report of three cases. Annals of Internal Medicine 43 241-254.
31. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A & Grobbee DE 1999 Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. European Heart Journal 20 447-455.
32. Owecki M, Michalak A, Nikisch E & Sowinski J 2006 Prolonged ventricular repolarization measured by corrected QT interval (QTc) in subclinical hyperthyroidism. Hormone Metabolic Research 38 44-47.
33. Passino C, Franzoni F, Gabutti A, Poletti R, Galetta F & Emdin M 2004 Abnormal ventricular repolarization in hypertensive patients: role of sympatho-vagal imbalance and left ventricular hypertrophy. Internal Journal of Cardiology 97 57-62.
34. Piotrowicz K, Zareba W, McNitt S & Moss AJ 2007 Repolarization duration in patients with conduction disturbances after myocardial infarction. American Journal of Cardiology 99 163-168.
35. Polikar R, Burger AG, Scherrer U & Nicod P 1993 The thyroid and the heart. Circulation 87 1435-1441.
36. Roden DM 2004 Drug-induced prolongation of the QT interval. New England Journal of Medicine 350 1013-1022.
37. Sarma JS, Venkataraman K, Nicod P, Polikar R, Smith J, Schoenbaum MP & Singh BN 1990 Circadian rhythmicity of rate-normalized QT interval in hypothyroidism and its significance for development of class III antiarrhythmic agents. American Journal of Cardiology 66 959-963.
38. Sharp NA, Neel DS & Parsons RL 1985 Influence of thyroid hormone levels on the electrical and mechanical properties of rabbit papillary muscle. Journal of Molecular and Cellular Cardiology 17 119-132.
39. Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH et al. 2006 Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. Journal of the American College of Cardiology 47 362-367.
40. Trantow T, Herzog R, Gegenheimer L & Lucker PW 1994 A new method for the determination of the bioavailability of thyroid hormone preparations. Methods and Findings in Experimental and Clinical Pharmacology 16 133-140.
41. Vliegenthart R, Oudkerk M, Song B, van der Kuip DA, Hofman A & Witteman JC 2002 Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. European Heart Journal 23 1596-1603.
42. Volpe R 1997 Rational use of thyroid function tests. Critical Reviews in Clinical Laboratory Sciences 34 405-438.
43. WHO 1999 World Health Organization-International Society of hypertension guidelines for the management of hypertension. Guidelines Subcommittee. Journal of Hypertension 17 151-183.
44. WHO Diabetes Mellitus 1985. Technical Reports series 894. Geneva: World Health Organisation.
45. Willems JL, Arnaud P, van Bemmel JH, Bourdillon PJ, Degani R, Denis B, Graham I, Harms FM, Macfarlane PW, Mazzocca G et al. 1987 A reference data base for multilead electrocardiographic computer measurement programs. Journal of the American College of Cardiology 10 1313-1321.
46. Willems JL, Abreu-Lima C, Arnaud P, van Bemmel JH, Brohet C, Degani R, Denis B, Gehring J, Graham I, van Herpen G et al. 1991 The diagnostic performance of computer programs for the interpretation of electrocardiograms. New England Journal of Medicine 325 1767-1773.
47. Yap YG & Camm AJ 2003 Drug induced QT prolongation and torsades de pointes. Heart 89 1363-1372.
48. Zahringer S, Tomova A, von Werder K, Brabant G, Kumanov P & Schopohl J 2000 The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis. Experimental and Clinical Endocrinology and Diabetes 108 282-289.